Smita C. Banerjee, PhD

Behavioral Scientist

Smita C. Banerjee, PhD

Behavioral Scientist
Smita Banerjee

Office Phone



PhD, Rutgers University

Dr. Smita C. Banerjee is an Associate Member at Memorial Sloan Kettering Cancer Center (MSK), as well as an Associate Attending Behavioral Scientist on the Behavioral Sciences Service in the Department of Psychiatry and Behavioral Sciences. 

Prior to joining MSK’s faculty, Dr. Banerjee received a Bachelor of Science in Home Science from Delhi University in India (1996), a Master of Science in Communication Media for Children from Srimati Nathibai Damodar Thakersey (SNDT) University in India (1998), and a PhD in Health Communication from Rutgers University (2005). 

Dr. Banerjee’s research focuses on the science of effective healthcare delivery and gaining a better understanding of communication between patients and healthcare providers using both observational and interventional methods. As a member of the research faculty of the Communication Skills (Comskil) Training and Research Laboratory, she serves as an educator and collaborative investigator supporting the Comskil Training Program, an intensive didactic and experiential training effort for MSK residents, fellows, nurses, and attendings focusing on common challenges faced in communication with patients with cancer and their families.

She is currently co-leading a national multi-site trial to promote the destigmatization of interactions with oncology care providers treating patients diagnosed with lung cancer. She has authored more than 100 articles in journals including Patient Education and Counseling, Translational Behavioral Medicine, and Journal of Health Communication. Dr. Banerjee has received research grant funding from the National Cancer Institute, National Institute on Drug Abuse, and the American Cancer Society.


View a full list of Dr. Banerjee’s journal articles.

Banerjee SC, Staley JM, Alexander K, Walters CB, Parker PA. Encouraging patients to disclose their lesbian, gay, bisexual, or transgender (LGBT) status: oncology health care providers’ perspectives. Transl Behav Med. 2020;10(4):918-927. doi:10.1093/tbm/iby105

Banerjee SC, Sussman A, Schofield E, et al. “Let’s Talk about Skin Cancer”: Examining Association between Family Communication about Skin Cancer, Perceived Risk, and Sun Protection Behaviors. J Health Commun. 2021;26(8):576-585. doi:10.1080/10810730.2021.1966686

Read more

Banerjee SC, Haque N, Bylund CL, et al. Responding empathically to patients: a communication skills training module to reduce lung cancer stigma. Transl Behav Med. 2021;11(2):613-618. doi:10.1093/tbm/ibaa011

Banerjee SC, Haque N, Schofield EA, et al. Oncology Care Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma. Chest. 2021;159(5):2040-2049. doi:10.1016/j.chest.2020.11.024

Banerjee SC, Staley JM, Howell F, et al. Communicating Effectively via Tele-oncology (Comskil TeleOnc): a Guide for Best Practices for Communication Skills in Virtual Cancer Care. J Cancer Educ. 2022;37(5):1343-1348. doi:10.1007/s13187-021-01959-7


Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Smita C. Banerjee discloses the following relationships and financial interests:

  • REAL Prevention LLC
    Intellectual Property Rights

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].

View all disclosures